Bvf Partners L P/il

Bvf Partners L P/il is listed in filings as Director, otherSee Remarks & Footnotes at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2026, including sale activity and purchase activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR), XOMA Royalty Corp. (XOMA), Third Harmonic Bio, Inc. (THRD), and Repare Therapeutics Inc. (RPTX). The current snapshot covers public activity from Jun 18, 2024 to Jun 25, 2026. Reported amounts are shown as $606.0K to $8.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.